← All companies
EVGN
Evogene Ltd.
$0.54
+0.05 +9.39%
Key statistics
from XBRL data in SEC filingsMarket cap
$4.67M
Revenue (TTM)
—
Net income (TTM)
—
EPS (TTM)
—
P/E ratio
—
Dividend yield
—
Free cash flow
—
Cash
—
Total assets
—
Gross margin
—
52-week range
$0.37 – $1.50
Recent SEC filings
40 most recentAnnual, quarterly & current reports
6-K
Jul 31, 2026
6-K
Jul 17, 2026
6-K
Jun 16, 2026
6-K
Jun 11, 2026
6-K
May 20, 2026
6-K
May 18, 2026
6-K
Apr 2, 2026
20-F
Mar 26, 2026
6-K
Mar 5, 2026
6-K
Feb 25, 2026
6-K
Feb 11, 2026
6-K
Feb 4, 2026
6-K
Jan 15, 2026
6-K
Dec 30, 2025
6-K
Nov 20, 2025
6-K
Sep 30, 2025
6-K
Sep 10, 2025
6-K
Aug 19, 2025
6-K
Aug 18, 2025
6-K
Aug 11, 2025
6-K
Jul 17, 2025
6-K
Jul 8, 2025
6-K
Jun 17, 2025
6-K
Jun 5, 2025
6-K
May 21, 2025
6-K
Apr 21, 2025
20-F
Mar 27, 2025
6-K
Mar 6, 2025
6-K
Mar 6, 2025
6-K
Feb 12, 2025
6-K
6K
Feb 5, 2025
6-K
Jan 15, 2025
6-K
Dec 30, 2024
6-K
Nov 27, 2024
6-K
Nov 21, 2024
6-K
Sep 17, 2024
6-K
Sep 16, 2024
6-K
Aug 23, 2024
6-K
Aug 22, 2024
6-K
Aug 12, 2024